Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Universal Electronics
UEIC
$57.8M
| $8.11M | 0.01% |
155,123
+42,900
| +38% | +$2.3M |
|
1577
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
| $8.1M | 0.01% |
238,254
+219,904
| +1,198% | +$7.37M |
|
|
CHUY
1578
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $8.1M | 0.01% |
312,494
+48,594
| +18% | +$1.26M |
|
|
FPRX
1579
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.09M | 0.01% |
1,761,971
+427,080
| +32% | +$1.69M |
|
|
MAXR
1580
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $8.07M | 0.01% |
+515,302
| New | +$5.35M |
|
1581
Fossil Group
FOSL
$293M
| $8.04M | 0.01% |
1,020,748
-245,902
| -19% | -$2.27M |
|
1582
CTS Corp
CTS
$1.83B
| $8.04M | 0.01% |
267,900
+14,900
| +6% | +$432K |
|
1583
Shore Bancshares
SHBI
$819M
| $8.03M | 0.01% |
462,353
+15,158
| +3% | +$248K |
|
1584
Champion Homes
SKY
$4.37B
| $8.02M | 0.01% |
253,120
+235,320
| +1,322% | +$7.33M |
|
1585
C&F Financial
CFFI
$268M
| $8.02M | 0.01% |
145,000
+2,100
| +1% | +$112K |
|
|
MRTX
1586
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8M | 0.01% |
62,100
-293,800
| -83% | -$28.3M |
|
|
SAGE
1587
DELISTED
Sage Therapeutics
SAGE
| $7.98M | 0.01% |
+110,591
| New | +$13.6M |
|
|
PBPB
1588
DELISTED
Potbelly
PBPB
| $7.98M | 0.01% |
1,890,500
-19,300
| -1% | -$84.2K |
|
1589
Stratasys
SSYS
$679M
| $7.97M | 0.01% |
394,152
-600,980
| -60% | -$12M |
|
1590
G. Willi-Food International
WILC
$373M
| $7.96M | 0.01% |
665,812
+1,000
| +0.2% | +$11.5K |
|
1591
Installed Building Products
IBP
$6.01B
| $7.94M | 0.01% |
115,300
+74,397
| +182% | +$5.02M |
|
1592
Kirby Corp
KEX
$7.01B
| $7.93M | 0.01% |
+88,600
| New | +$7.34M |
|
1593
Brinker International
EAT
$9.17B
| $7.93M | 0.01% |
188,711
+177,311
| +1,555% | +$7.64M |
|
|
SMMF
1594
DELISTED
Summit Financial Group, Inc.
SMMF
| $7.92M | 0.01% |
292,435
+10,000
| +4% | +$264K |
|
1595
Safe Bulkers
SB
$795M
| $7.9M | 0.01% |
4,648,389
+227,403
| +5% | +$395K |
|
|
ACOR
1596
DELISTED
Acorda Therapeutics
ACOR
| $7.87M | 0.01% |
32,144
-1,659
| -5% | -$419K |
|
|
TGE
1597
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $7.87M | 0.01% |
+355,538
| New | +$6.82M |
|
1598
Elbit Systems
ESLT
$37.9B
| $7.85M | 0.01% |
50,600
-28,100
| -36% | -$4.58M |
|
|
GSS
1599
DELISTED
Golden Star Resources Ltd.
GSS
| $7.82M | 0.01% |
2,051,660
-332,936
| -14% | -$1.06M |
|
1600
Xenon Pharmaceuticals
XENE
$6.06B
| $7.81M | 0.01% |
595,677
+107,077
| +22% | +$1.13M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.